LONDON – After marathon negotiations, SkyePharma plc reached agreement on restructuring £83 million (US$131.2 million) of bond debt, avoiding the obligation to make payments – that it could not possibly have afforded – of £68.4 million in 2013 and £21.6 million in 2014.